A retrospective study of disease modifying therapy in patients with Radiologically Isolated Syndrome
Latest Information Update: 26 Mar 2021
At a glance
- Drugs Dimethyl fumarate (Primary) ; Fingolimod (Primary) ; Glatiramer acetate (Primary) ; Mycophenolate mofetil (Primary) ; Ocrelizumab (Primary) ; Teriflunomide (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 26 Mar 2021 New trial record
- 27 Feb 2021 Results presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2021